Corporate Information | Press & Media | For Investors

ThinkGenetic

ThinkGenetic

Finding Patients At Risk for Rare Disease

  • Home
  • Solutions
    • FindEHR™
    • FindSM™
  • Research
    • Medical Publications
    • Technical Research
  • About
    • Team
    • Board
    • Partners
  • News & Events
  • Contact
  • Request a Demo

Research in Artificial Intelligence for Rare Genetic Diseases

November 11, 2021 by Sarika Kondra

There are over 7000 rare genetic disorders (RGD) and only 5% of them have FDA approved treatments. Though the number of RGDs is high, they are heterogenous and geographically disparate. […]

Technical Research artificial intelligence, rare genetic disease, research, Sarika Kondra

Application of Natural Language Processing in Clinical Applications

October 14, 2021 by Sarika Kondra

Natural Language Processing is a field of computational linguistics, computer science and more specially artificial intelligence (AI) that uses statistics, machine learning (ML) and deep learning (DL) techniques to understand […]

News, Technical Research AI, artificial intelligence, big data, data, De-identification of records, dependency parsing, lemmatization, Named Entity Recognition, Natural Language Processing, Negation Detection, NLP, part-of-speech, Part-of-Speech Tagging, POS Tagging, Relation Extraction, Sarika Kondra, Sentence Tokenization, stemming, Stemming and Lemmatization, tokenization, unstructured data, Word Tokenization

[Press Release] Massachusetts Startup Wins Horizon Prize, Powered by MIT Solve, with Algorithm-Based FindEHR Solution for Finding Undiagnosed Genetic Disorder Patients using Electronic Medical Records

October 7, 2021 by Ruth O'Keefe

ThinkGenetic combines modern machine learning with practical information in genetics to solve a major concern in healthcare – the identification of patients living with undiagnosed rare genetic conditions Boston, MA, […]

Investor News, News, Press Releases AI, algorithm, artificial intelligence, Boston startup, Dave Jacob, electronic health records, FindEHR, Horizon Prize, Horizon Therapeutics, machine learning, Massachusetts Institute of Technology, medical health records, MIT Solve, ThinkGenetic, Tim Walbert, undiagnosed patients

[Press Release] Ochsner Lafayette Healthcare Innovation Fund Invests in ThinkGenetic Vision for Genetic Disease Identification in Local Patients

April 20, 2021 by Ruth O'Keefe

ThinkGenetic, Inc. announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund.

Investor News, News, Press Releases artificial intelligence, Dave Jacob, genetic disease, Healthcare Innovation Fund, Lafayette, Lafayette General Health Systems, machine learning, Ochsner, Ochsner Lafayette General, Rare Disease, SymptomMatcher, ThinkGenetic

Upcoming Events

  • There are no upcoming events.

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

  • Solutions
    • FindEHR™
    • FindSM™
  • Resources
    • Contact
    • Research
    • FAQs
  • About ThinkGenetic
    • Team
    • Board
    • Investors
    • Careers
  • Legal
    • Disclaimers
    • Privacy Policy

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.

©2023 ThinkGenetic. All Rights Reserved.